The International Hospital Federation (IHF) online tuberculosis manual toolkit for hospital decision-makers presented at Lilly MDR-TB Partnership Sixth Annual Summit, 2-4 December 2009, Cancun, Mexico

The IHF, represented by Sheila Anazonwu, Programme Development & Knowledge Manager, presented to partners of the Lilly MDR-TB Partnership and attendees of the 40th Union Against Tuberculosis and Lung Disease International Conference its online tuberculosis manual toolkit for hospital decision makers.

The manual toolkit is available at http://www.ihf-fih.org/toolkit/index.html#PageReady and on CD-ROM. Creation of this training material, a deliverable of IHF’s four-year (2008-2011) Phase II bilateral partnership programme, sponsored by the Lilly MDR-TB Partnership, is in recognition of the need to address TB management within hospital and healthcare settings and making hospital and healthcare decision makers aware of the challenges and ensure their engagement in the fight against TB. The IHF has been a Partnership member since 2004.

This Lilly MDR-TB Partnership Summit, held annually, provides an opportunity to learn about recent MDR-TB trends, the current status of the Lilly MDR-TB Partnership, and brainstorm on the strategic opportunities for the upcoming years in the fight against MDR-TB as well as build momentum especially in South Africa, China, India, and Russia, the 4 high-burden countries of focus.

The Summit events involve Focus Country Roundtables as well as partner bilateral meetings. In the 2009 event, Regional roundtables were also hosted for the first time covering Francophone Africa, Eastern Mediterranean, Europe and Latin America. During the Roundtables, discussions were held with partners and WHO regional representatives to explore and determine collaborative strategies for TB and MDR-TB control in the respective regions. There was also a Partnership booth in the UNION Exhibit Hall, at which material on all partner activities were made available. Members of the Partnership were able to interact and engage with UNION conference attendees.

The Lilly MDR-TB Partnership, led by Eli Lilly and Company, is a public-private initiative that consists of an alliance of the following global partner organizations: The Advocacy Partnership, Akorn, Aspen Pharmacare, Eli Lilly and Company, Global Business Coalition (GBC), Global Health Advocates (GHA), Harvard University and Partners in Health (PIH), Hisun Pharmaceutical, International Council of Nurses (ICN), International Federation of Red Cross and Red Crescent Societies (IFRC), International Hospital Federation (IHF), Purdue University, Results Educational Fund, Shasun Chemicals and Drugs, SIA International/Biocom, Stop TB Partnership, TB Alert, U.S. Centers for Disease Control and Prevention (CDC), Vianex S.A., World Economic Forum (WEF), World Health Organization (WHO), World Medical Association (WMA).

Its mission is to address the expanding crisis of multi-drug resistant tuberculosis (MDR-TB), through pursuit of a comprehensive strategy to fight MDR-TB through increasing drug supply at concessionary prices; research; providing training in prevention, treatment, and surveillance; promoting awareness and community support programs and sharing drug manufacturing technology with nations most at risk of MDR-TB. The Partnership is working worldwide in over 80 countries with the local TB and health authorities, NGOs and representatives of the Global Partners, and is focusing on four high-burden countries: China, India, Russia and South Africa.
For more information: sheila@ihf-fih.org

< Back to main